Biomerica, Inc.
BMRA
$3.93
$0.08812.29%
NASDAQ
| 02/28/2025 | 11/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -31.60% | -9.46% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -31.60% | -9.46% | |||
| Cost of Revenue | -8.26% | -21.01% | |||
| Gross Profit | -95.65% | 51.21% | |||
| SG&A Expenses | -13.73% | -13.75% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -11.41% | -17.20% | |||
| Operating Income | -21.85% | 27.41% | |||
| Income Before Tax | -22.46% | 27.36% | |||
| Income Tax Expenses | -33.33% | -175.00% | |||
| Earnings from Continuing Operations | -22.42% | 27.81% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -22.42% | 27.81% | |||
| EBIT | -21.85% | 27.41% | |||
| EBITDA | -22.45% | 27.91% | |||
| EPS Basic | -9.19% | 29.03% | |||
| Normalized Basic EPS | -9.20% | 28.54% | |||
| EPS Diluted | -1.00% | 25.00% | |||
| Normalized Diluted EPS | -9.20% | 28.54% | |||
| Average Basic Shares Outstanding | 12.06% | 1.78% | |||
| Average Diluted Shares Outstanding | 12.06% | 1.78% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||